PRLD

3.2250.92%
VS

Victor Sandor

Independent Director

Dr. Victor Sandor, CM, M.D., FRCPC is Director of Mestag Therapeutics Ltd from October 2026. Dr. Sandor has been an Independent Director at AbCellera Biologics Inc. since June 2026. Dr. Sandor serves as Independent Director of Kymera Therapeutics, Inc. since November 2022. Dr. Sandor serves as an Independent Non-Executive Director at ADC Therapeutics SA since April 2020. Dr. Sandor has been Independent Director at Prelude Therapeutics Incorporated since May 2020. He served as Independent Non-Executive Director at Merus N.V. since June 2019 until December 11, 2025 and served as its Board Observer from January 2019 until June 2019. Dr. Sandor served as the Chief Medical Officer of Array BioPharma Inc. since September 22, 2014 to December 2019, where he oversaw clinical development through regulatory approval of Braftovi® and Mektovi® for the treatment of BRAFV600E/K mutant melanoma and Braftovi for the treatment of BRAFV600E mutant colorectal cancer. Dr. Sandor has more than a decade of experience in the pharmaceutical and biotechnology industries. From February 2010 to September 2014, Dr. Sandor served as Senior Vice President of Drug Development/Global Clinical Development of Incyte Corporation. From February 2010 to September 2014, Dr. Sandor was also Vice President and Chief Medical Officer for Oncology at Biogen Idec and from October 2009 until February 2010, held positions of increasing responsibility in oncology product development at AstraZeneca, where he played an important role in the registration of Arimidex® (anastrozole) for adjuvant use and the development of several early stage programs through proof-of-concept. Dr. Sandor joined Incyte as Vice President Global Oncology Drug Development in February 2010. Dr. Sandor is a board-certified medical oncologist with experience in both academic and private oncology practice. Dr. Sandor also served as a Director of Istari Oncology, Inc. from July 2019 to January 2026 Dr. Sandor completed Fellowship in Medical Oncology at the National Institutes of Health in Bethesda, Maryland and earned medical degree (MD, CM) from McGill University in Montreal.

Positions